Gabelli & Co Investment Advisers’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$325K Hold
2,700
0.05% 199
2025
Q4
$284K Sell
2,700
-300
-10% -$28.2K 0.04% 191
2025
Q3
$252K Hold
3,000
0.04% 199
2025
Q2
$237K Hold
3,000
0.04% 204
2025
Q1
$269K Buy
+3,000
New +$280K 0.04% 174
2022
Q1
Sell
-3,000
Closed -$230K 519
2021
Q4
$230K Sell
3,000
-444
-13% -$35.4K 0.03% 338
2021
Q3
$259K Hold
3,444
0.03% 300
2021
Q2
$268K Sell
3,444
-165
-5% -$12.3K 0.03% 283
2021
Q1
$265K Buy
3,609
+524
+17% +$38.7K 0.03% 282
2020
Q4
$241K Buy
3,085
+360
+13% +$27.5K 0.04% 237
2020
Q3
$216K Buy
+2,725
New +$213K 0.04% 176

Other funds holding MRK

Gabelli & Co Investment Advisers's MRK Position: Q1 2026 in Review

Gabelli & Co Investment Advisers held its Merck (MRK) position steady in Q1 2026 at 2,700 shares worth $325K. The position accounts for 0.05% of the portfolio, ranked #199.

Gabelli & Co Investment Advisers first reported a position in MRK in Q3 2020 and has held it in 11 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Gabelli & Co Investment Advisers held 2,700 shares of Merck worth $325K as of Q1 2026.
  • Gabelli & Co Investment Advisers left its Merck share count unchanged in Q1 2026.
  • Merck made up 0.05% of Gabelli & Co Investment Advisers's portfolio in Q1 2026, its #199 holding.
  • Gabelli & Co Investment Advisers first reported a position in Merck in Q3 2020 and has held it in 11 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.